FDA rejects Vernalis’ cough cold treatment
admin 21st April 2017 Uncategorised 0The US Food and Drug Administration has rejected Vernalis’ cough cold treatment CCP-07, which is being developed by US partner Tris Pharma.
More: FDA rejects Vernalis’ cough cold treatment
Source: News